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causes infections in humans. Here we report the case of an
8-month-old infant who presented with an acute febrile illness.
During the diagnostic process, a blood culture was positive with
Gram-positive cocci that were identified as Brachybacterium
nesterenkovii by MALDI-TOF. As a result of the unclear clinical
significance of this isolate and the continuous febrile state, a
second blood culture was taken and returned B. nesterenkovii
once more. To our knowledge this is the first time that
B. nesterenkovii has been isolated from human blood cultures
during the course of a systemic infection.
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Brachybacterium was first proposed by Collins et al. in 1988 [1].
Since then, a total of 22 Brachybacterium species have been
identified in various ecological niches, in animal and human
specimens [2–4]. Infections in humans, in particular systemic
infections, are rare.
Brachybacterium nesterenkovii was first described by Gvoz-
dyak et al. in 1992 and was only the second identified species
belonging the genus Brachybacterium [5]. It is non-motile,
non-spore-forming, not acid fast, Gram-positive, either cocci
or bacilli depending on growth cycle stage, and forms yellowish
colonies [5,6]. Brachybacterium nesterenkovii has been isolated
from milk products, bioaerosols and root canal infections
[5,7,8]. However, to our knowledge, no systemic infection with
this particular species has been reported so far. Here we report
the first documented case of a bloodstream infection caused by
B. nesterenkovii.
Case
An 8-month old male infant was presented to a migrant clinic
on the Thailand-Myanmar border with a 2-day history of fever,
watery stool, vomiting and reduced urine output. The infant
was born at term at an estimated gestational age of 38+2
(weeks+days), to a mother with an unremarkable pregnancy.
Before the onset of symptoms, the infant’s development was
normal, and the vaccination schedule was up to date.
On presentation, the infant was alert with a Blantyre coma
scale score of 5. Examination of heart, lungs and the abdomen
were unremarkable but there were signs of dehydration and
the weight was measured at 7.5 kg (8th centile according to the
WHO weight-for-age growth scale). The initial heart rate was
165 beats/minute, the respiratory rate 40 breaths/minute, pe-
ripheral oxygen saturation 97% on room air and the body
temperature was 38.4°C.
A peripheral malaria smear and a microscopic stool exami-
nation for intestinal helminth and protozoal infection were
negative. The white blood cell (WBC) count was 11.1 × 109/L
(5.82 × 109 to 13.77 × 109/L, population adjusted reference
interval (RI) for this age group [9]), with a 74.4% neutrophil
predominance in the differential count (RI 9%–50%) and C-
reactive protein was 30.6 mg/L (reference <8 mg/L). At 106 g/L
(RI 103–150) and 35.1% (RI 30.4%–46.0%), respectively, the
haemoglobin and haematocrit were normal. Moreover, an
aerobic blood culture was obtained (BacT/ALERT® PF, bio-
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form of parenteral fluid replacement (20 mL/kg normal saline
bolus, followed by a 2 mL/kg Ringer lactate maintenance dose),
oral rehydration (240mL STAT dose) and paracetamol (15mg/kg
four times a day) was provided. Additionally, as per local treat-
ment protocols, zinc (15 mg once daily) and vitamin B1 (50 mg
once daily) were supplemented.
On the second day of admission, the infant was still febrile
and in addition to the gastrointestinal symptoms, crackles over
both lungs had developed and chest indrawing was noted. There
were still signs of dehydration and the infant was increasingly
irritable. As there was concern of sepsis and as the infant did not
tolerate oral medication, empiric antibiotic treatment with
parenteral ceftriaxone (50 mg/kg) was commenced.
On day three the BacT/ALERT® microbial detection system
indicated a positive result and Gram-positive cocci were seen.
The bacterial colonies were non-haemolytic on the sheep blood
agar plate, catalase positive, coagulase negative (Staphaurex™
Latex Agglutination Test; Thermo Fisher Scientific, Waltham,
MA, USA) and DNase negative. Further identification of the
isolate by matrix-assisted laser desorption ionization time-of-
flight mass spectrometry (MALDI-TOF) (VITEK MS, bio-
Mérieux, Marcy l’Etoile, France) confirmed B. nesterenkovii with
a 99.9% certainty.
As it was not clear whether this isolate represented a true
bacteraemia or a contaminant, and as the infant was still febrile
and showed clinical symptoms that were compatible with a
lower respiratory tract infection, it was decided to repeat the
blood culture. In the meantime, the antibiotic regimen was
continued and while the result of the second blood culture was
still pending, the clinical condition improved and the fever
subsided.
Four days after the second blood culture was taken, the
BacT/ALERT® microbial detection system flagged positive and
once again non-haemolytic, catalase-positive, coagulase-FIG. 1. Brachybacterium nesterenkovii colonies after 48 hours incubation on b
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yellow/cream tinge were isolated (Fig. 1). As before, the isolate
was identified as B. nesterenkovii by MALDI-TOF with a confi-
dence of 99.9%.
When this second result became known 4 days after spec-
imen collection, the infant was already free of symptoms and 7
days of antibiotic treatment were completed. White blood cell
counts (11.3 × 109/L) and C-reactive protein (<8 mg/L) were
within normal limits in a repeated complete blood count.
Anaemia was noted (haemoglobin 95 g/L), so anaemia treat-
ment with ferrous sulphate, folic acid and multivitamin
supplementation was prescribed, and the infant was discharged
home on day nine after admission. Two weeks after initial
presentation, when the infant was followed up in the outpatient
department, all symptoms had subsided, and he was fully
recovered.DiscussionIn a comprehensive search of published literature, no case of a
systemic infection with B. nesterenkovii was identified, making
this report the first one, to our knowledge.
Over recent years, MALDI-TOF has become an established
tool for accurate identification of a broad spectrum of bacteria
in clinical microbiology [10]. With the identification of a
broader spectrum of pathogens, clinicians are increasingly
confronted with rarely identified bacterial species, and the
associated question of whether isolates represent a true
infection or a contaminant; misinterpretation of findings can
lead to dire consequences [11]. Initially it was not entirely clear
whether the isolated bacterium was a true infection or due to
contamination. The facts that this particular bacterium was
isolated twice from the same patient and no other agent thatlood agar.
nses/by-nc-nd/4.0/).
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indicators for a true infection [11].
Reports of bacteraemia caused by Brachybacteria in humans
are extremely scarce. Unclassified Brachybacteria strains were
isolated by lysis filtration from blood samples of children who
underwent dental procedures [12]. These isolates were taken
from healthy children without signs of systemic infections.
Interestingly, Brachybacteria were more often isolated at base-
line, before the dental procedures (three before versus two
after dental procedures) [12].
To our knowledge there is only one report of a symptomatic
systemic infection with a Brachybacterium reported by Tamai
et al., who isolated a strain that was closely related to Brachy-
bacterium squillarum in a blood culture [13]. In this region Bra-
chybacteria species have been detected in nasopharyngeal swabs
using 16S rRNA sequencing [14], but no systemic infections
have been encountered.
The empiric antibiotic choice was based on the patient’s
presentation and as there was uncertainty of the significance of
this isolate, the clinical course determined the subsequent
management. As a result of the absence of antimicrobial sus-
ceptibility testing protocols, no antibiogram was available.
Although the infant was still febrile when the second blood
culture was acquired, the overall condition was stable and
shortly thereafter the clinical symptoms subsided. Conse-
quently, a full course of ceftriaxone was given and led to clinical
cure. Similarly, in the case reported by Tamai et al., cefazolin, a
first-generation cephalosporin, was clinically effective for a
different Brachybacterium sp.
Brachybacterium nesterenkovii was first isolated from milk
products [5] and also recovered from dental root canal in-
fections [8]. Unfortunately, no apparent source of the blood-
stream infection was identified in this case.
In conclusion, this is the first documented case of a systemic
and symptomatic bloodstream infection in a human caused by
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